These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 2417213)

  • 21. A novel functional cell surface dimer (Kp43) expressed by natural killer cells and gamma/delta TCR+ T lymphocytes. II. Modulation of natural killer cytotoxicity by anti-Kp43 monoclonal antibody.
    Aramburu J; Balboa MA; Izquierdo M; López-Botet M
    J Immunol; 1991 Jul; 147(2):714-21. PubMed ID: 1830071
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of effector mechanisms against HTLV-I- and HTLV-III/LAV-infected lymphoid cells.
    Ruscetti FW; Mikovits JA; Kalyanaraman VS; Overton R; Stevenson H; Stromberg K; Herberman RB; Farrar WL; Ortaldo JR
    J Immunol; 1986 May; 136(10):3619-24. PubMed ID: 2422259
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human natural killer cells: biologic and pathologic aspects.
    Trinchieri G; Perussia B
    Lab Invest; 1984 May; 50(5):489-513. PubMed ID: 6201674
    [No Abstract]   [Full Text] [Related]  

  • 24. Mechanism of defective NK cell activity in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. II. Normal antibody-dependent cellular cytotoxicity (ADCC) mediated by effector cells defective in natural killer (NK) cytotoxicity.
    Katz JD; Mitsuyasu R; Gottlieb MS; Lebow LT; Bonavida B
    J Immunol; 1987 Jul; 139(1):55-60. PubMed ID: 3584988
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human clones with natural killer function can activate B cells and secrete B cell differentiation factors.
    Vyakarnam A; Brenner MK; Reittie JE; Houlker CH; Lachmann PJ
    Eur J Immunol; 1985 Jun; 15(6):606-10. PubMed ID: 3924630
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Is the NK lytic process involved in the mechanism of NK suppression of antibody-producing cells?
    Targan S; Brieva J; Newman W; Stevens R
    J Immunol; 1985 Feb; 134(2):666-9. PubMed ID: 2578158
    [No Abstract]   [Full Text] [Related]  

  • 27. Immunologic monitoring of the renal transplant recipient.
    Suthanthiran M; Garovoy MR
    Urol Clin North Am; 1983 May; 10(2):315-25. PubMed ID: 6222530
    [No Abstract]   [Full Text] [Related]  

  • 28. Monoclonal antibodies against leucoagglutinin-reactive human T lymphocyte surface components. Two antibodies which inhibit cell-mediated cytotoxicity at a post-binding stage.
    Vargas-Cortes M; Hammarström ML; Hammarström S; Hellström U; Perlmann P
    Eur J Immunol; 1986 Jul; 16(7):795-801. PubMed ID: 3522246
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interferon and cyclic nucleotides.
    Tovey MG
    Interferon; 1982; 4():23-46. PubMed ID: 6195113
    [No Abstract]   [Full Text] [Related]  

  • 30. Immunoelectron microscopic application of monoclonal antibodies for identification of lymphocyte subsets bearing tubuloreticular inclusions or parallel tubular arrays.
    Kang YH; Yaffe L; Grimley PM
    J Exp Pathol; 1984; 1(2):157-73. PubMed ID: 6100980
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Subpopulations of human natural killer cells defined by expression of the Leu-7 (HNK-1) and Leu-11 (NK-15) antigens.
    Lanier LL; Le AM; Phillips JH; Warner NL; Babcock GF
    J Immunol; 1983 Oct; 131(4):1789-96. PubMed ID: 6225799
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Natural and antibody-dependent killer cells in the thymus.
    Zöller M; Andrighetto G; Heyman B
    Eur J Immunol; 1982 Nov; 12(11):914-21. PubMed ID: 6185347
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Interferon influences the immunologic defense of the body--an important physiological immunity-regulating function?].
    Kiessling R; Gidlund M
    Lakartidningen; 1985 Jul; 82(30-31):2593-7. PubMed ID: 2410747
    [No Abstract]   [Full Text] [Related]  

  • 34. Human lymphocyte subpopulations: analysis by multiparameter flow cytometry and monoclonal antibodies.
    Warner NL
    Cancer Detect Prev Suppl; 1987; 1():515-23. PubMed ID: 3500782
    [No Abstract]   [Full Text] [Related]  

  • 35. Separation and isolation of rat natural killer (NK) cells from T cells with monoclonal antibodies.
    Woda BA; McFadden ML; Welsh RM; Bain KM
    J Immunol; 1984 May; 132(5):2183-4. PubMed ID: 6609190
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enrichment of rat NK cytotoxicity for H2-negative murine embryonal carcinoma cells by panning and short-term culture in TCGF.
    Bell SM; Aspinall R; Stern PL
    Immunology; 1984 Sep; 53(1):23-32. PubMed ID: 6332064
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development and distribution of a human B cell subpopulation identified by the HB-4 monoclonal antibody.
    Tedder TF; Clement LT; Cooper MD
    J Immunol; 1985 Mar; 134(3):1539-44. PubMed ID: 3918104
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [NK activity and the number of HNK-1+ cells in relation to age and sex].
    Písa P; Strejcek J; Horký J; Suhajová E; Hudoba P; Jíra M
    Cas Lek Cesk; 1984 Nov; 123(48):1466-9. PubMed ID: 6545780
    [No Abstract]   [Full Text] [Related]  

  • 39. Recombinant interleukin 2 enhanced natural killer cell-mediated cytotoxicity in human lymphocyte subpopulations expressing the Leu 7 and Leu 11 antigens.
    Lanier LL; Benike CJ; Phillips JH; Engleman EG
    J Immunol; 1985 Feb; 134(2):794-801. PubMed ID: 3871216
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interleukin-2- and mitogen-activated NK-like killer cells from highly purified human peripheral blood T cell (CD3+ N901-) cultures.
    Atzpodien J; Wisniewski D; Gulati S; Welte K; Knowles R; Clarkson B
    Nat Immun Cell Growth Regul; 1987; 6(3):129-40. PubMed ID: 3114621
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.